More States Follow Oregon’s Lead Toward Legal Psilocybin Therapy

New York and Washington consider bills to legalize the medical use of psilocybin, while Colorado voters might establish medical frameworks for psilocybin therapy this November.

DEA Proposes Adding Five Psychedelic Compounds to Schedule 1

Concerned scientists say that the proposal will inevitably hamper vital research of nearly 100 related compounds.

How is Oregon Preparing for the Facilitated Use of Psilocybin?

Oregon is innovating the first legal system in the U.S. to train and regulate facilitators of psilocybin experiences.

Health Canada Takes Small Step Towards Accessible Psychedelic Medicine

Canada has loosened restrictions for doctors to use MDMA and psilocybin to treatment-resistant conditions and terminally ill patients, but the approval process is slower than some patients can afford.

Texas Leads the Way in Bi-Partisan Support for Psychedelic-Assisted Therapy Research

Pioneering research into psilocybin for treating veterans with PTSD has made Republicans like Rick Perry unlikely allies with Democrats in the Texas legislature.

Detroit Votes to Decriminalize Psychedelics

On Tuesday, Detroit citizens passed a ballot that makes plant-based psychedelics the lowest priority for law enforcement.

Statewide Psychedelic Decriminalization Efforts Are Growing Across the Nation

Elected representatives across the country have proposed bills that would allow for research into psychedelics and others that would decriminalize psychedelic drugs at the state level.

In Defense of Ketamine: Five Questions For Ismail Lourido Ali of MAPS

The director of policy for MAPS discusses why ketamine was removed from the California decrim bill and the possible benefits of decriminalizing personal adult use of ketamine.

What Is the Future of the California Decrim Bill?

The bill, SB 519, is on hold to allow a coalition of supporters to build support for the bill among legislators.

House Report Calls on NIH to Study Psychedelic-Assisted Therapies

In “smoke signal” to federal agencies, a House Committee report urges government funded psychedelic research.